Simply Wall St User's Discussions - Simply Wall St

SI

Simply Wall St User

Community Contributor

Member since 2026

Views

0

Fair Values Set

0

Comments

1

Followers

0

No bio added yet

No link added

IOVA·about 17 hours agoUS Launch And Global Expansion Will Create New Opportunities

Wayne Rothbaum runs Iovance Biotherapeutics so their interim CEO is a non-issue. Also, the demand for global approvals by analysts and Wall Street is also not a necessary strategic move considering scaling patients in North America is financially and more easily obtainable to scale to 10000 or more patients by 2030 especially when considering insurance reimbursements are much higher than Europe or Asia that is a can of worms.

0

|

0